|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the UCLA School of Medicine (Mr. Simmons and Drs. Nides and Tashkin), Los Angeles, CA; and Johns Hopkins University School of Medicine (Drs. Rand and Wise), Baltimore, MD.
Correspondence to: Michael Simmons, Department of Medicine, Division of Pulmonary and Critical Care Medicine, UCLA, Los Angeles, CA 90095-1690; e-mail: msimm{at}ucla.edu
Objective: To identify subject characteristics that may be predictive of intentional dumping of metered-dose inhalers (MDIs) during a clinical trial.
Design: Nebulizer Chronologs (NCs; Medtrac Technologies; Lakewood, CO), which record the date and time of each MDI actuation, were attached to the MDIs of participants who were given a prescribed medication schedule to follow in a clinical trial. Participants were not informed of the function of the NC or that their medication use was being monitored.
Setting: The Lung Health Study, a 5-year clinical trial to evaluate the effect of intensive smoking cessation counseling and regular use of an inhaled bronchodilator on the progression of COPD.
Participants: One hundred one smokers, 35 to 60 years of age, with mild to moderate airways obstruction enrolled in The Lung Health Study.
Measurements and results: Thirty of
these 101 participants (30%) actuated their inhalers > 100 times
within a 3-h interval on at least one occasion during the first year of
this 5-year trial. Only 1 of an additional 135 participants who had
full foreknowledge of the MDI monitoring capability of the NC did so.
Most of these dumping episodes occurred shortly before a clinic
follow-up visit, suggesting an active attempt to hide noncompliance
from the clinic staff. Whereas self-reported inhaler usage and canister
weights were similar for the "dumpers" and "nondumpers," NC
data indicated significantly lower compliance rates for dumpers
(
2; p < 0.05). When demographic variables, treatment
and clinic assignments, smoking status, pulmonary function test
results, respiratory symptoms, and disease history of dumpers and
nondumpers were analyzed, no predictors of dumping could be found.
Conclusions: Deception among noncompliers occurs frequently in clinical trials, is often not revealed by the usual methods of monitoring, and cannot be predicted by data readily available in clinical trials.
Key Words: COPD electronic monitoring devices metered-dose inhalers patient compliance
This article has been cited by other articles:
![]() |
D L Cullen Long term oxygen therapy adherence and COPD: what we don't know Chronic Respiratory Disease, November 1, 2006; 3(4): 217 - 222. [Abstract] [PDF] |
||||
![]() |
D. Wendler and F. G. Miller Deception in the Pursuit of Science Arch Intern Med, March 22, 2004; 164(6): 597 - 600. [Full Text] [PDF] |
||||
![]() |
J. A. Clowes, N. F. A. Peel, and R. Eastell The Impact of Monitoring on Adherence and Persistence with Antiresorptive Treatment for Postmenopausal Osteoporosis: A Randomized Controlled Trial J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1117 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nakanishi, A. K. Klasner, and B. K. Rubin A Randomized Controlled Trial of Inhaled Flunisolide in the Management of Acute Asthma in Children Chest, September 1, 2003; 124(3): 790 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Bies, M. R. Gastonguay, K. C. Coley, P. D. Kroboth, and B. G. Pollock Evaluating the Consistency of Pharmacotherapy Exposure by Use of State-of-the-Art Techniques Am J Geriatr Psychiatry, December 1, 2002; 10(6): 696 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Koller, S. Malozowski, S. Johnson, M. S. Simmons, and D. P. Tashkin Deception in Bronchodilator Inhaler Use Chest, April 1, 2001; 119(4): 1291 - 1292. [Full Text] [PDF] |
||||
![]() |
S. Malozowski, E. Koller, M. S. Simmons, and D. P. Tashkin Compliance With Bronchodilator Treatment Chest, March 1, 2001; 119(3): 988 - 989. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |